In an effort to promote cross-border innovation, investment, and technological exchange between EBPMN and India, EBPMN and ABLE enter into this Memorandum of Understanding on 8th May 2024. The aim of this collaboration is to promote technology and technology- based investment, facilitate business expansion in India and low and middle-income countries; enhancing the global access of biopharmaceuticals by facilitating local manufacturing capacity in India and low and middle-income countries, and supporting collaborative research and development in areas of common interest between ABLE and EBPMN.

The MoU was signed by Mr. Narayanan Suresh, Chief Operating Officer of ABLE and Mr. Syed S Ahmed, Vice President & Board Member of EBPMN and CEO & Director of TechInvention Lifecare Pvt. Ltd.

The Emerging Biopharmaceutical Manufacturers Network (EBPMN), formally established as an international non-profit association in the Netherlands, the EBPMN Secretariat is now hosted in Butantã in São Paulo, Brazil with its registered headquarters in Mumbai, India and aims to expand biopharmaceutical access in low- and middle-income countries (LMICs) by fostering local manufacturing capacity and promoting sustainable practices, paving the way for a healthier and more equitable world. Visit the website www.ebpmn.tech

The MoU was signed by Mr. Narayanan Suresh, Chief Operating Officer of ABLE and Mr. Syed S Ahmed, Vice President & Board Member of EBPMN and CEO & Director of TechInvention Lifecare Pvt. Ltd.